Ahmed J H, Elliott H L, Hosie J, Farish E, Reid J L
University Department of Medicine and Therapeutics, Stobhill General Hospital, Glasgow, UK.
J Hum Hypertens. 1992 Apr;6(2):139-44.
In a placebo-controlled, double-blind, randomised, cross-over study the metabolic and hormonal responses to standard food and exercise challenge have been evaluated in seven patients with mild to moderate essential hypertension after treatment with nicardipine 30 mg three times daily for four weeks. There were no significant differences between nicardipine and placebo for any of the measured hormonal and metabolic indices following food or exercise. These results indicate that nicardipine has no clinically important effects on serum lipids or hormonal or metabolic responses to food and exercise.
在一项安慰剂对照、双盲、随机、交叉研究中,对7例轻度至中度原发性高血压患者进行了评估,这些患者每天三次服用30毫克尼卡地平,持续四周,之后接受标准食物和运动刺激,观察其代谢和激素反应。在食物或运动后,所测量的任何激素和代谢指标在尼卡地平组和安慰剂组之间均无显著差异。这些结果表明,尼卡地平对血脂或对食物和运动的激素或代谢反应没有临床重要影响。